Does the treatment of cardiac failure depend on its cause, ischaemic or idiopathic?;Le traitement de l'insuffisance cardiaque est-il different selon sa cause, ischemique ou idiopathique?

Archives des Maladies du Coeur et des Vaisseaux

Volumn 92, Issue 6, 1999, Pages 727-732

  Galinier, M ^b   Bounhoure, J P ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMLODIPINE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; WARFARIN;

CARDIOMYOPATHY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; ORAL DRUG ADMINISTRATION; REVIEW;

CARDIOMYOPATHY, DILATED; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 0033019141     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Cohn JN, Johnson G, Ziesche S et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure : Ve-HeFT-II. N Engl J Med 1991 ; 325 : 303-10.
2. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991 ; 325 : 293-302.
3. The CIBIS Investigators. A randomised trial of β-blockade in heart failure. Circulation 1994 ; 90 : 1765-73.
4. Adams KF Jr, Geaorhiade M, Uretsky BF et al. Patients with mild heart failure worsen during withdrawal from digoxin therapy. J Am Coll Cardiol 1997 ; 30 : 42-8.
5. Anand IS. Digitalis in the 21st century. In : Mc Murray JJV, Cleland JGF, (eds). Heart failure in clinical practice. London : Marin Dunitz Ltd, 1996 : 237-55.
6. Digitalis Investigators Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997 ; 336 : 525-33.
7. Singh SN, Fletcher RD, Fisher SG et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995 ; 333 : 77-82.
8. Packer M, O'Connor CM, Ghali JK et al, for the PRAISE Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996 ; 335 : 1107-14.
9. O'Connor CM, Carson PE, Miller AB et al, for the PRAISE Investigators. Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Am J Cardiol 1998 ; 82 : 881-7.
10. Follath F, Cleland JGF, Klein W, Murphy R. Etiologiy and response to drug treatment in heart failure. J Am Coll Cardiol 1998 ; 32 : 1167-72.
11. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995 ; 273 : 1450-6.
12. Waagstein F, Bristow MR, Swedburg K et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993 ; 342 : 1441-6.
13. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999 ; 353 : 9-13.
14. Packer M, Bristow MR, Cohn JN et al, for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996 ; 334 : 1349-55.
15. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Cruid R. Randomised trial of low dose amiodarone in severe congestive heart failure. Lancet 1994 ; 344 : 493-8.
16. Julian DG, Camm AJ, Frangin G et al, for the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997 ; 349 : 667-74.
17. Al-Khadra AS, Salem DN, Rand WM, Udelson JF, Smith JS, Konstam MA. Warforin anticoagulation and survival : a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol 1998 ; 31 : 749-53.
18. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997 ; 18 : 736-53.